3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
164
Lung Neoplasms
61
Small Cell Lung Carcinoma
24
Neoplasms
10
NSCLC
9
Mesothelioma, Malignant
9
Breast Neoplasms
8
Pancreatic Neoplasms
7
Ovarian Neoplasms
7
Melanoma
6
Head and Neck Neoplasms
6
Colorectal Neoplasms
6
Esophageal Neoplasms
5
Stomach Neoplasms
4
Neoplasm Metastasis
4
Mesothelioma
4
Kidney Neoplasms
4
Brain Neoplasms
4
Sarcoma
3
Pleural Effusion, Malignant
3
Liver Neoplasms
3
Fallopian Tube Neoplasms
3
Cholangiocarcinoma
3
Carcinoma
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Thymus Neoplasms
2
Thymoma
2
Small Cell Lung Cancer Limited Stage
2
Skin Neoplasms
2
Interventions
Cisplatin
6
Etoposide
5
Topotecan
4
Carboplatin
4
Pemetrexed
3
Gemcitabine
3
belinostat
2
Temozolomide
2
RRx-001
2
vosaroxin
1
vinflunine
1
veliparib
1
taxane
1
sagopilone
1
sacituzumab govitecan
1
pembrolizumab
1
lurtotecan
1
liposomal doxorubicin
1
enzalutamide
1
bemiparin
1
belotecan
1
atezolizumab
1
apalutamide
1
alvocidib
1
abiraterone
1
Vinorelbine
1
Tomography, X-Ray Computed
1
Sorafenib
1
Rhenium
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Small Cell
×
Drug Therapy
×
Thoracic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled